Global LIMS market to grow to $3.56bn by 2030
Research suggests rising demand for lab automation will help promote the growth of the laboratory information management system (LIMS) market.
List view / Grid view
Research suggests rising demand for lab automation will help promote the growth of the laboratory information management system (LIMS) market.
26 August 2014 | By AstraZeneca
AstraZeneca announced that it has entered into a collaboration with gene sequencing company, Illumina, Inc., to develop its next generation sequencing platform for companion diagnostic tests applicable across AstraZeneca’s oncology portfolio...
18 April 2012 | By Roche
Roche released the following statement based on preliminary estimates...
6 April 2012 | By Roche
Roche released the following statement in response to a report issued by Institutional Shareholder Services...
29 March 2012 | By Roche
Roche increases offer price for gene sequencing firm Illumina to US$ 51.00 per share...
13 March 2012 | By Roche
The 2nd request seeks additional information regarding Roche’s microarray business...
27 January 2012 | By Roche
Roche has commenced a cash tender offer to acquire all outstanding shares of Illumina, Inc....
26 January 2012 | By Roche
Roche has responded to an announcement from Illumina, Inc...
25 January 2012 | By Roche
Roche announced that it is proposing to acquire all outstanding shares of Illumina, Inc...
In this Genomics / Sequencing supplement: NGS powers up drug discovery and healthcare; Impact of novel sequencing technology on transcriptome analysis; Making sense of nonesense (and missense): Bringing the results of recent genetic studies into the drug discovery laboratory...
RNA-Seq is a powerful sequencing-based method that enables researchers to discover, profile, and quantify RNA transcripts across the entire transcriptome.